Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mycoses ; 57(7): 406-13, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24612078

ABSTRACT

Many relapses and deaths resulting from disseminated histoplasmosis (DH) in acquired immunodeficiency syndrome (AIDS) patients have been observed in an endemic area in north-eastern Brazil. The objective of this study was to evaluate the risk factors associated with the clinical outcomes of DH/AIDS coinfection in patients from the state of Ceará, Brazil. A retrospective cohort of AIDS patients, after their hospital discharge due to first DH episode in the period 2002-2008, was followed until December 31, 2010, to investigate the factors associated with relapse and mortality. A total of 145 patients were evaluated in the study. Thirty patients (23.3%) relapsed and the overall mortality was 30.2%. The following variables were significantly (P < 0.05) associated with relapse and overall mortality (univariate analysis): non-adherence to highly active antiretroviral therapy (HAART), irregular use of an antifungal, non-recovery of the CD4+ count and having AIDS before DH; histoplasmosis relapse was also significantly associated with mortality. In the multivariate analysis, non-adherence to HAART was the independent risk factor that was associated with both relapse (Adj OR = 6.28) and overall mortality (Adj OR = 8.03); efavirenz usage was discovered to be significant only for the overall mortality rate (Adj OR = 4.50). Adherence to HAART was the most important variable that influenced the outcomes in this specific population.


Subject(s)
AIDS-Related Opportunistic Infections/mortality , HIV Infections/microbiology , Histoplasmosis/mortality , Histoplasmosis/virology , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/epidemiology , Adult , Antifungal Agents/therapeutic use , Antiretroviral Therapy, Highly Active/methods , Brazil/epidemiology , Coinfection/epidemiology , Coinfection/microbiology , Coinfection/mortality , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , HIV Infections/mortality , Histoplasmosis/drug therapy , Histoplasmosis/epidemiology , Humans , Male , Recurrence , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...